FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W187314932> ?p ?o ?g. }

• W187314932 endingPage "76" @default.
• W187314932 startingPage "72" @default.
• W187314932 abstract "Hemospray (Cook Medical, USA) has recently been approved in Canada for the management of nonvariceal upper gastrointestional bleeding (UGIB).To review the authors' experience with the safety and efficacy of Hemospray for treating UGIB.A retrospective chart review was performed on patients who required endoscopic evaluation for suspected UGIB and were treated with Hemospray.From February 2012 to July 2013, 19 patients (mean age 67.6 years) with UGIB were treated with Hemospray. A bleeding lesion was identified in the esophagus in one (5.3%) patient, the stomach in five (26.3%) and duodenum in 13 (68.4%). Bleeding was secondary to peptic ulcers in 12 (63.2%) patients, Dieulafoy lesions in two (10.5%), mucosal erosion in one (5.3%), angiodysplastic lesions in one (5.3%), ampullectomy in one (5.3%), polypectomy in one (5.3%) and an unidentified lesion in one (5.3%). The lesions showed spurting hemorrhage in four (21.1%) patients, oozing hemorrhage in 11 (57.9%) and no active bleeding in four (21.1%). Hemospray was administered as monotherapy in two (10.5%) patients, first-line modality in one (5.3%) and rescue modality in 16 (84.2%). Hemospray was applied prophylactically to nonbleeding lesions in four (21.1%) patients and therapeutically to bleeding lesions in 15 (78.9%). Acute hemostasis was achieved in 14 of 15 (93.3%) patients. Rebleeding within seven days occurred in seven of 18 (38.9%) patients. Potential adverse events occurred in two (10.5%) patients and included visceral perforation and splenic infarct. Mortality occurred in five (26.3%) patients but the cause of death was unrelated to gastrointestinal bleeding with the exception of one patient who developed hemoperitoneum.The high rates of both acute hemostasis and recurrent bleeding suggest that Hemospray may be used in high-risk cases as a temporary measure or a bridge toward more definitive therapy." @default.
• W187314932 created "2016-06-24" @default.
• W187314932 creator A5008733161 @default.
• W187314932 creator A5010036349 @default.
• W187314932 creator A5018739654 @default.
• W187314932 creator A5022127071 @default.
• W187314932 creator A5039205971 @default.
• W187314932 creator A5041709827 @default.
• W187314932 creator A5044752032 @default.
• W187314932 creator A5054061492 @default.
• W187314932 creator A5056906130 @default.
• W187314932 date "2014-01-01" @default.
• W187314932 modified "2023-10-12" @default.
• W187314932 title "Safety and Efficacy of Hemospray^®in Upper Gastrointestinal Bleeding" @default.
• W187314932 cites W109776944 @default.
• W187314932 cites W1971866699 @default.
• W187314932 cites W1982743136 @default.
• W187314932 cites W2001731112 @default.
• W187314932 cites W2039839114 @default.
• W187314932 cites W2043138736 @default.
• W187314932 cites W2052030900 @default.
• W187314932 cites W2065863738 @default.
• W187314932 cites W2073541764 @default.
• W187314932 cites W2075444744 @default.
• W187314932 cites W2077751285 @default.
• W187314932 cites W2094747908 @default.
• W187314932 cites W2100239503 @default.
• W187314932 cites W2109525960 @default.
• W187314932 cites W2112091799 @default.
• W187314932 cites W2133233018 @default.
• W187314932 cites W2162414953 @default.
• W187314932 cites W2319063013 @default.
• W187314932 doi "https://doi.org/10.1155/2014/759436" @default.
• W187314932 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4071892" @default.
• W187314932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24501723" @default.
• W187314932 hasPublicationYear "2014" @default.
• W187314932 type Work @default.
• W187314932 sameAs 187314932 @default.
• W187314932 citedByCount "77" @default.
• W187314932 countsByYear W1873149322014 @default.
• W187314932 countsByYear W1873149322015 @default.
• W187314932 countsByYear W1873149322016 @default.
• W187314932 countsByYear W1873149322017 @default.
• W187314932 countsByYear W1873149322018 @default.
• W187314932 countsByYear W1873149322019 @default.
• W187314932 countsByYear W1873149322020 @default.
• W187314932 countsByYear W1873149322021 @default.
• W187314932 countsByYear W1873149322022 @default.
• W187314932 countsByYear W1873149322023 @default.
• W187314932 crossrefType "journal-article" @default.
• W187314932 hasAuthorship W187314932A5008733161 @default.
• W187314932 hasAuthorship W187314932A5010036349 @default.
• W187314932 hasAuthorship W187314932A5018739654 @default.
• W187314932 hasAuthorship W187314932A5022127071 @default.
• W187314932 hasAuthorship W187314932A5039205971 @default.
• W187314932 hasAuthorship W187314932A5041709827 @default.
• W187314932 hasAuthorship W187314932A5044752032 @default.
• W187314932 hasAuthorship W187314932A5054061492 @default.
• W187314932 hasAuthorship W187314932A5056906130 @default.
• W187314932 hasBestOaLocation W1873149321 @default.
• W187314932 hasConcept C126322002 @default.
• W187314932 hasConcept C141071460 @default.
• W187314932 hasConcept C167135981 @default.
• W187314932 hasConcept C191897082 @default.
• W187314932 hasConcept C192562407 @default.
• W187314932 hasConcept C197934379 @default.
• W187314932 hasConcept C2776259030 @default.
• W187314932 hasConcept C2776345487 @default.
• W187314932 hasConcept C2776809568 @default.
• W187314932 hasConcept C2778451229 @default.
• W187314932 hasConcept C2778456384 @default.
• W187314932 hasConcept C2778527123 @default.
• W187314932 hasConcept C2778589496 @default.
• W187314932 hasConcept C2779390736 @default.
• W187314932 hasConcept C2779422922 @default.
• W187314932 hasConcept C2780656511 @default.
• W187314932 hasConcept C2781156865 @default.
• W187314932 hasConcept C71924100 @default.
• W187314932 hasConceptScore W187314932C126322002 @default.
• W187314932 hasConceptScore W187314932C141071460 @default.
• W187314932 hasConceptScore W187314932C167135981 @default.
• W187314932 hasConceptScore W187314932C191897082 @default.
• W187314932 hasConceptScore W187314932C192562407 @default.
• W187314932 hasConceptScore W187314932C197934379 @default.
• W187314932 hasConceptScore W187314932C2776259030 @default.
• W187314932 hasConceptScore W187314932C2776345487 @default.
• W187314932 hasConceptScore W187314932C2776809568 @default.
• W187314932 hasConceptScore W187314932C2778451229 @default.
• W187314932 hasConceptScore W187314932C2778456384 @default.
• W187314932 hasConceptScore W187314932C2778527123 @default.
• W187314932 hasConceptScore W187314932C2778589496 @default.
• W187314932 hasConceptScore W187314932C2779390736 @default.
• W187314932 hasConceptScore W187314932C2779422922 @default.
• W187314932 hasConceptScore W187314932C2780656511 @default.
• W187314932 hasConceptScore W187314932C2781156865 @default.
• W187314932 hasConceptScore W187314932C71924100 @default.
• W187314932 hasIssue "2" @default.
• W187314932 hasLocation W1873149321 @default.

• next